Anxiety disorders are among the most common mental illnesses – and many sufferers want “natural” treatment options in addition to or as an alternative to conventional psychotropic drugs. For some herbal active ingredients – in particular standardized lavender oil, kava (Piper methysticum), ashwagandha (Withania somnifera), passion flower (Passiflora incarnata) and chamomile (Matricaria chamomilla) – a clinical database of randomized studies, systematic reviews and meta-analyses is now available. This shows that there are demonstrable anxiolytic effects, albeit with varying effect strengths, quality levels and safety profiles. The article summarizes the current evidence and outlines the clinical situations in which phytotherapeutic options can be usefully integrated – without replacing guideline-based therapies.
Autoren
- Tanja Schliebe
Publikation
- PHYTOTHERAPIE PRAXIS
You May Also Like
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations
Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis
- Cellular and Systemic Iron Homeostasis
“Steady State” – a delicately balanced equilibrium
- Psychedelic-assisted therapy
Current status of PAT
- First-line treatment for T2D